Cell viability of U251 cells overexpressing FGFR1-EGFP was strongly increased by SPRY2-OE even after cisplatin treatment, which confirms our previous study that SPRY2-OE increases tumor growth of U251 xenografts in mice [43]. This evidence concerns the gene SPRY2 and neoplasm.